These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38897255)

  • 21. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
    Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
    Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gangliosides in Axon Stability and Regeneration.
    Lopez PHH; Báez BB
    Prog Mol Biol Transl Sci; 2018; 156():383-412. PubMed ID: 29747821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantobodies activate small GTPase RhoA to modulate neurite outgrowth.
    Sheikh KA
    Small GTPases; 2011 Jul; 2(4):233-238. PubMed ID: 22145097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration.
    Vyas AA; Patel HV; Fromholt SE; Heffer-Lauc M; Vyas KA; Dang J; Schachner M; Schnaar RL
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8412-7. PubMed ID: 12060784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
    Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
    Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.
    Asthana P; Vong JS; Kumar G; Chang RC; Zhang G; Sheikh KA; Ma CH
    Mol Neurobiol; 2016 Sep; 53(7):4981-91. PubMed ID: 26374552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.
    Yamagishi Y; Kuwahara M; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida KI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1339-1342. PubMed ID: 33041261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.
    Kusunoki S; Kaida K; Ueda M
    Biochim Biophys Acta; 2008 Mar; 1780(3):441-4. PubMed ID: 17976386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.
    Ang CW; Yuki N; Jacobs BC; Koga M; Van Doorn PA; Schmitz PI; Van Der Meché FG
    Neurology; 1999 Dec; 53(9):2122-7. PubMed ID: 10599792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
    Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
    Brain; 2000 Jan; 123 ( Pt 1)():116-24. PubMed ID: 10611126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes.
    Shahrizaila N; Kokubun N; Sawai S; Umapathi T; Chan YC; Kuwabara S; Hirata K; Yuki N
    Neurology; 2014 Jul; 83(2):118-24. PubMed ID: 24920848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
    Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
    Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
    Odaka M; Koga M; Yuki N; Susuki K; Hirata K
    J Neurol Sci; 2003 Jun; 210(1-2):99-103. PubMed ID: 12736097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin KM allotypes are associated with the prevalence of autoantibodies to GD1a ganglioside, but not with susceptibility to the disease, in Japanese patients with Guillain-Barré syndrome.
    Pandey JP; Koga M; Yuki N
    Neurogenetics; 2005 Dec; 6(4):225-8. PubMed ID: 16258760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.